Repurposing Siponimod for Alzheimer's Disease

NCT06639282 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease
Mild Alzheimer Disease
MCI With Increased Risk for Alzheimer Disease
Cognitive Impairment, Mild

Interventions

DRUG: Siponimod
DRUG: Placebo

Sponsor

St. Joseph's Hospital and Medical Center, Phoenix

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]